PURE Bioscience reports FY 2024 net loss of $3.4M; product sales up 4.5% to $1.955M

PURE BIOSCIENCE, INC.

Net product sales $1.955M in FY 2024 vs $1.871M in FY 2023, up $84K (4.5%).
Net loss improved to ($3.4M) from ($3.9M); net loss per share ($0.03) vs ($0.04).
Net cash used in operations reduced to ($2.5M) from ($3.3M).
Shifted strategy to distribution model; partnered with multiple distributors in fiscal 2024.
R&D focused on Clean-in-Place solutions for food processing equipment sanitation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.